These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12069439)

  • 21. An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence.
    Chandra A; Glickman SW; Ou FS; Peacock WF; McCord JK; Cairns CB; Peterson ED; Ohman EM; Gibler WB; Roe MT
    Ann Emerg Med; 2009 Jul; 54(1):17-25. PubMed ID: 19282062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods.
    Pieper KS; Tsiatis AA; Davidian M; Hasselblad V; Kleiman NS; Boersma E; Chang WC; Griffin J; Armstrong PW; Califf RM; Harrington RA
    Circulation; 2004 Feb; 109(5):641-6. PubMed ID: 14769687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of ethnic differences in affecting the outcomes of international trials.
    Cheng TO
    Eur Heart J; 2002 Feb; 23(3):256. PubMed ID: 11792142
    [No Abstract]   [Full Text] [Related]  

  • 24. Thrombolysis in myocardial infarction (TIMI) phase II trial.
    N Engl J Med; 1989 Aug; 321(9):612. PubMed ID: 2503726
    [No Abstract]   [Full Text] [Related]  

  • 25. Biotechnology and clinical trials.
    Siegel JP
    J Infect Dis; 2002 Feb; 185 Suppl 1():S52-7. PubMed ID: 11865440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence.
    Topol EJ
    Circulation; 1998 Jan; 97(2):211-8. PubMed ID: 9445175
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute myocardial infarction: the 'mega-trial' era.
    Purcell H
    Br J Clin Pract; 1994; 48(2):60-1. PubMed ID: 8024989
    [No Abstract]   [Full Text] [Related]  

  • 28. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity.
    Böttiger BW; Padosch SA; Wenzel V
    N Engl J Med; 2002 Oct; 347(16):1281-2; author reply 1281-2. PubMed ID: 12393830
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter by Lozano et al regarding article, "Adjunctive thrombectomy for acute myocardial infarction: a bayesian meta-analysis".
    Lozano I; Avanzas P; Rondan J
    Circ Cardiovasc Interv; 2010 Jun; 3(3):e8; author reply e9. PubMed ID: 20551391
    [No Abstract]   [Full Text] [Related]  

  • 30. Genentech's boom is boosted by new clinical trial data.
    Barinaga M
    Nature; 1988 Mar; 332(6163):387. PubMed ID: 3127729
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase III: research designs for future studies.
    Splett PL
    J Am Diet Assoc; 1991 Nov; Suppl():S43-50. PubMed ID: 1939969
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pulmonary lymphangioleiomyomatosis: empiric treatment of controlled trial?].
    Orehek J
    Rev Mal Respir; 1996 Jul; 13(3):199-202. PubMed ID: 8765911
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute ischemic heart disease.
    Granger CB; Skene A
    Am Heart J; 2000 Apr; 139(4):S189-92. PubMed ID: 10740129
    [No Abstract]   [Full Text] [Related]  

  • 34. Controversies in the design of phase II clinical trials.
    Seymour L
    Clin Adv Hematol Oncol; 2010 Feb; 8(2):95-7. PubMed ID: 20386529
    [No Abstract]   [Full Text] [Related]  

  • 35. Caeteris paribus - all things being equal.
    Giugliano RP; Antman EM
    Eur Heart J; 2001 Dec; 22(24):2221-3. PubMed ID: 11728139
    [No Abstract]   [Full Text] [Related]  

  • 36. [Can the numerical and statistical strength of a mega trial with an intervention protocol wrong from the physiopathologic viewpoint lead to definitive conclusions?].
    Rossi P
    G Ital Cardiol; 1996 Apr; 26(4):459-62. PubMed ID: 8707031
    [No Abstract]   [Full Text] [Related]  

  • 37. The future of clinical research beyond phase III trials.
    Vogelbaum MA
    Clin Neurosurg; 2009; 56():37-9. PubMed ID: 20214028
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanical thrombectomy to the RESCUE.
    Bass TA
    Catheter Cardiovasc Interv; 2002 Feb; 55(2):244. PubMed ID: 11835657
    [No Abstract]   [Full Text] [Related]  

  • 39. The controlled clinical trial, single-case research, and the clinical laboratory.
    Scott FI
    Am Clin Lab; 1997 Apr; 16(3):4. PubMed ID: 10173022
    [No Abstract]   [Full Text] [Related]  

  • 40. [GISSI-3 research protocol (Italian Group for the Study of Survival in Myocardial Infarct)].
    G Ital Cardiol; 1991 Jul; 21(7):779-88. PubMed ID: 1765240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.